Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap® (XM17), Comparability with Gonal-f®, and Performance/Consistency
Crossref DOI link: https://doi.org/10.1007/s40268-017-0182-z
Published Online: 2017-04-06
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Winstel, Rainer
Wieland, Juergen
Gertz, Beate
Mueller, Arnd
Allgaier, Hermann
Funding for this research was provided by:
BioGeneriX AG, a member of the Teva group
License valid from 2017-04-06